Variant report
Variant | nsv820344 |
---|---|
Chromosome Location | chr5:178109175-178113753 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:178103410..178105385-chr5:178107182..178109270,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2086111 | chr5:178109201-178109202 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs373102482 | chr5:178109244-178109245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs367836267 | chr5:178109250-178109251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112369162 | chr5:178109259-178109260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182868377 | chr5:178109299-178109300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562509177 | chr5:178109314-178109315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188332718 | chr5:178109358-178109359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77223323 | chr5:178109395-178109396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191226974 | chr5:178109396-178109397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571198269 | chr5:178109433-178109434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375422294 | chr5:178109493-178109494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566677667 | chr5:178109511-178109512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533787528 | chr5:178109524-178109525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551959850 | chr5:178109538-178109539 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570301583 | chr5:178109548-178109549 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538793181 | chr5:178109553-178109554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557151639 | chr5:178109571-178109572 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183788892 | chr5:178109578-178109579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536265833 | chr5:178109586-178109587 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554903440 | chr5:178109594-178109595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573588435 | chr5:178109598-178109599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540918743 | chr5:178109601-178109602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565526427 | chr5:178109612-178109613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77271789 | chr5:178109687-178109688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199807838 | chr5:178109709-178109710 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs527659446 | chr5:178109814-178109815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544330490 | chr5:178109930-178109931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187720068 | chr5:178109962-178109963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73334803 | chr5:178109970-178109971 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs547877587 | chr5:178109972-178109973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192325644 | chr5:178109986-178109987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370153907 | chr5:178110014-178110015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113912126 | chr5:178110015-178110016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35128888 | chr5:178110030-178110031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527618714 | chr5:178110102-178110103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552047735 | chr5:178110103-178110104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57859218 | chr5:178110122-178110123 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs530955301 | chr5:178110130-178110131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185687817 | chr5:178110152-178110153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs377655403 | chr5:178110167-178110168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75531276 | chr5:178110170-178110171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569273625 | chr5:178110173-178110174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375127690 | chr5:178110207-178110208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368046926 | chr5:178110208-178110209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371904488 | chr5:178110214-178110215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534524234 | chr5:178110218-178110219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147120885 | chr5:178110229-178110230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577577409 | chr5:178110259-178110260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189877370 | chr5:178110290-178110291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138473306 | chr5:178110307-178110308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sotos syndrome | 21572526 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Sotos syndrome | 17561922 | CNVD |
Sotos syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Sotos syndrome | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Lung cancer | 17297452 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sotos syndrome | 22283845 | CNVD |
Breast cancer | 16272173 | CNVD |
Sotos syndrome | 20503325 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 19181860 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ehlers-danlos syndrome | 17576883 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19246517 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 21990379 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:178105400-178109400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr5:178105400-178109800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
3 | chr5:178109400-178110800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr5:178109800-178110800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr5:178110200-178113200 | Enhancers | Primary monocytes fromperipheralblood | blood |
6 | chr5:178110400-178111800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr5:178110800-178111200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr5:178110800-178111600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
9 | chr5:178110800-178111800 | Enhancers | K562 | blood |
10 | chr5:178110800-178112000 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
11 | chr5:178111600-178113400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
12 | chr5:178112000-178115400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
13 | chr5:178112200-178112800 | Enhancers | Placenta | Placenta |
14 | chr5:178112800-178113400 | Flanking Active TSS | Placenta | Placenta |
15 | chr5:178113200-178115200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
16 | chr5:178113400-178113800 | Enhancers | Placenta | Placenta |
17 | chr5:178113400-178115000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |